John T. Treace, Chief Executive Officer at Treace Medical Concepts, bought TMCI on Aug 24, 2026
Data as of Oct 16
▲ BUY$47.7K11,000 shares at $4.34John T. Treace Chief Executive OfficerTMCI Treace Medical Concepts, Inc.
- Traded
- Aug 24, 2026
- Disclosed
- Aug 24, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TMCI since disclosure
−11.4%
Similar stocks (XLV) since disclosure
+1.2%
XLV — its sector index fund
Change in closing price from Aug 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYJohn T. Treace Chief Executive OfficerTMCI Treace Medical Concepts, Inc.$21.7Kdisclosed Aug 24 · filed 3 days after the trade
- ▲ BUYJohn T. Treace Chief Executive OfficerTMCI Treace Medical Concepts, Inc.$177Kdisclosed Aug 24 · filed 4 days after the trade